Lisata Therapeutics, Inc.
LSTA
$1.09
-$0.04-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 34.75% | -51.96% | 30.48% | 8.80% | 1.38% |
| Total Depreciation and Amortization | 50.00% | -86.67% | -65.91% | 0.00% | 2.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.21% | -57.28% | 290.83% | -0.46% | -55.21% |
| Change in Net Operating Assets | -93.94% | 189.50% | -280.16% | 46.59% | 136.36% |
| Cash from Operations | 14.08% | 5.11% | 2.78% | 15.52% | 26.77% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 919.80% | -94.66% |
| Cash from Investing | -- | -- | -100.00% | 919.80% | -94.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.47% | 65.85% | -41.93% | 377.03% | -66.36% |
| Repurchase of Common Stock | 100.00% | -- | -- | 100.00% | 95.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -83.98% | -11.71% | -41.93% | 451.56% | 378.26% |
| Foreign Exchange rate Adjustments | -50.00% | 200.00% | 0.00% | -60.00% | 150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.63% | 4.80% | -240.64% | 163.96% | -184.38% |